2014
DOI: 10.1002/micr.22254
|View full text |Cite
|
Sign up to set email alerts
|

Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: Over 4 years follow-up

Abstract: Breast cancer-related lymphedema (LE) represents an important morbidity that jeopardizes breast cancer patients' quality of life. Different attempts to prevent LE brought about improvements in the incidence of the pathology but LE still represents a frequent occurrence in breast cancer survivors. Over 4 years ago, Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) was proposed and long-term results are reported in this study. From July 2008 to December 2012, 74 patients underwent axillary nodal disse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
171
3
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 214 publications
(180 citation statements)
references
References 17 publications
4
171
3
2
Order By: Relevance
“…For example, lymphatico-venous microsurgical anastamosis to maintain lymphatic outflow at the time of mastectomy and lymphadenectomy has shown promising results in preventing primary breast cancer-related lymphedema. 26 Pharmacologic agents that stimulate lymphangiogenesis, such as VEGF-C, may also have a role in the management of postsurgical lymphedema. 11 To assess novel surgical techniques and pharmacological therapies for lymphedema, it is imperative to develop clinically relevant and physiologically accurate animal models where controlled studies can be performed.…”
Section: Discussionmentioning
confidence: 99%
“…For example, lymphatico-venous microsurgical anastamosis to maintain lymphatic outflow at the time of mastectomy and lymphadenectomy has shown promising results in preventing primary breast cancer-related lymphedema. 26 Pharmacologic agents that stimulate lymphangiogenesis, such as VEGF-C, may also have a role in the management of postsurgical lymphedema. 11 To assess novel surgical techniques and pharmacological therapies for lymphedema, it is imperative to develop clinically relevant and physiologically accurate animal models where controlled studies can be performed.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the numerous efforts to reduce complication rates after ilioinguinal lymphadenectomy, the treatment and prevention of lymphedema remains a true challenge. 1,2 In our study, multiple lymphatic-venous anastomoses (MLVA) was performed immediately after groin dissection (lymphatic microsurgical preventive healing approach [LYMPHA] 3,4 ). This report describes the LYMPHA procedure in the groin and its implications for morbidity and lymphedema prevention.…”
Section: Discussionmentioning
confidence: 99%
“…In cases where crossover of SLNB/ALND and ARM-nodes are present in the axillary dissection plain, lymphatic venous anastomosis are made after dissection in order to restore the upper-extremity lymphatic drainage system. After a 4-year follow-up, the Boccardo group reported a lymphedema incidence rate of 4% (3/74) [36]. Although it concerns only a small study, these results are quite promising, when compared with the incidence of BCRL after ALND and SLNB, 20% and 6% respectively [4].…”
Section: Surgical Interventions For Lymphedema Prevention and Treatmentmentioning
confidence: 93%